Advertisement

Integra LifeSciences Holdings Corp. said Wednesday it received Food and Drug Administration clearance to sell its Vu aPOD Prime anterior lumbar interbody fusion device.

The device is used for a procedure to treat back pain by fusing vertebrae.

Integra said the market for such procedures is estimated to be about $425 million in 2010.

Advertisement
Advertisement